Publications Archive

Sort by Articles: Date | Author

Sort by Working Papers: Date | Author

Articles

  • Pransky, Glenn, Ernst R. Berndt, Stan N. Finkelstein, et al.. Performance Decrements Resulting From Illness in the Workplace:  The Effect of Headaches Journal of Occupational & Environmental Medicine, 47(1): 34-40, January 2005.
  • Wan, George J., William H. Crown, Ernst R. Berndt, et al. Healthcare Expenditures in Patients Treated with Venlafaxine or Selective Serotonin Reuptake Inhibitors for Depression and Anxiety, International Journal of Clinical Practice, 56(6): 434-439, July/August 2002.
  • Wan, George J., William H. Crown, Ernst R. Berndt, et al. Treatment Costs of Venlafaxine or Selective Serotonin Reuptake Inhibitors for Depression and Anxiety Managed Care Interface, 15(6): 24-30, June 2002.
  • Rosenthal, Meredith B., Ernst R. Berndt, Julie M. Donohue, et al. Promotion of Prescription Drugs to Consumers, The New England Journal of Medicine, 346(7): 498-505, February 2002.
  • Cockburn, Iain M. and Rebecca M. Henderson. Scale and Scope in Drug Development: Unpacking the Advantages of Size in Pharmaceutical Research Journal of Health Economics, 20(6): 1033-1057, November 2001.
  • Ellison, Sara F. and Wallace P. Mullin. Gradual Incorporation of Information:  Pharmaceutical Stocks and the Evolution of President Clinton’s Health Care Reform The Journal of Law & Economics, XLIV(1): 89-129, April 2001.
  • Berndt, Ernst R. The U.S. Pharmaceutical Industry:  Why Significant Growth in Times of Cost Containment? Health Affairs (Project Hope), 20(2): 100-114, March / April 2001.
  • Cockburn, Iain M., Rebecca Henderson and Scott Stern. Untangling the Origins of Competitive Advantage Strategic Management Journal, 21(10/11): 1123, October/November 2000.
  • Berndt, Ernst R., Howard L. Bailit, Martin B. Keller, et al. Health Care Use and At-Work Productivity Among Employees with Mental Disorders Health Affairs, 19(4): 224-256, July / August 2000.
  • Berndt, Ernst R., Lorrin M. Koran, Stan N. Finkelstein, et al. Lost Human Capital from Early-Onset Chronic Depression American Journal of Psychiatry, 157(6): 940-947, June 2000.
  • Berndt, Ernst R., Salvatore N. Colucci, Amy N. Grudzinski, et al. Comparing SSRI Treatment Costs for Depression Using Retrospective Claims Data:  The Role of Nomrandom Selection and Skewed Data Value in Health, 3(3): 208 - 227, May / June 2000.
  • Berndt, Ernst R. International Comparisons of Pharmaceutical Prices:  What Do We Know, and What Does It Mean? Journal of Health Economics, 19(2): 283-287, April 2000.
  • Berndt, Ernst R., David M. Cutler, Richard G. Frank, et al. Medical Care Prices and Output In Anthony C. Culyer and Joseph P. Newhouse (eds.), Handbook of Health Economics, Amsterdam: Elsevier Science, 1A: 120-130, 2000.
  • Cockburn, Iain M., Howard L. Bailit, Ernst R. Berndt, et al. Loss of Work Productivity Due to Illness and Medical TreatmentJournal of Occupational and Environmental Medicine, 41(11): 948-953, November 1999.
  • Cremieux, Pierre-Yves, Stan N. Finkelstein, Ernst R. Berndt, et al. Cost-Effectiveness, Quality-Adjusted Life Years, and Supportive Care: Recombinant Human Erythropoietin as a Treatment of Cancer-Associated Anaemia PharmacoEconomics, 16(5 Pt 1): 459-472, November 1999.
  • Finkelstein, Stan N., Paul E. Greenberg, Anthony Sisitsky, et al. The Economic Burden of Anxiety Disorders in the 1990s Journal of Clinical Psychiatry, 60(7): 427-435, July 1999.
  • Cockburn, Iain M., Howard L. Bailit and Stan Finkelstein. When Antihistamines Go To Work Business and Health, 17(3): 49-50, March 1999.
  • Berndt, Ernst R., Stan N. Finkelstein, Paul E. Greenberg, et al. Workplace Performance Effects From Chronic Depression and its Treatment Journal of Health Economics, 17: 511-535, October 1998.
  • Cockburn, Iain M. and Rebecca Henderson. Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery Journal of Industrial Economics, 46(2): 157-182, 1998.
  • Ellison, Sara F., Iain Cockburn, Zvi Griliches, et al. Characteristics of Demand for Pharmaceutical Products:  An Examination of Four Cephalosporins RAND Journal of Economics, 28(3): 426-446, Fall 1997.
  • Cockburn, Iain M. and Rebecca M. Henderson. Public‑Private Interaction in Pharmaceutical Research National Academy of Sciences of the United States of America, 93(23): 12725-12730, November 1996.
  • Greenberg, Paul E., Stan N. Finkelstein and Ernst R. Berndt. Calculating the Workplace Cost of Chronic Disease Business and Health, 13(9): 27-28, 30, September 1995.
  • Berndt, Ernst R., Zvi Griliches and Joshua G. Rosett. Auditing the Producer Price Index: Micro Evidence from Prescription Pharmaceutical Preparations Journal of Business & Economic Statistics, 11(3): 14, 251, July 1993.
  • Finkelstein, Stan N., Ernst R. Berndt, Paul E. Greenberg, et al. Improvement in Subjective Work Performance After Treatment of Chronic Depression: Some Preliminary Results Psychopharmacology Bulletin, 32(1): 33–40, Spring 1996.
  • Henderson, Rebecca M. and Iain M. Cockburn. Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery Rand Journal of Economics, 27(1): 32-59, Spring 1996.
  • Greenberg, Paul E., Stan N. Finkelstein and Ernst R. Berndt. Economic Consequences of Illness in the Workplace Sloan Management Review, 36(4): 26-38, Summer 1995.
  • Berndt, Ernst R., Linda T. Bui, David H. Reiley, et al. Information, Marketing, and Pricing in the U.S. Anti-Ulcer Drug Market The American Economic Review, 85(2): 100-105, May 1995.
  • Neels, Kevin, Stan N. Finkelstein and Chester Douglass. Medical Cost Savings from Pentoxifylline Therapy, PharmacoEconomics, 5(2): 130–140, February 1994.
  • Henderson, Rebecca M. Managing Innovation in the Information Age Harvard Business Review, 72(1): 6, 100, January/February 1994.
  • Henderson, Rebecca M. and Iain M. Cockburn. Measuring Competence? Exploring Firm Effects in Pharmaceutical Research Strategic Management Journal (Special Issue: Competitive Organizational Behavior), 15: 63-84, Winter 1994.
  • Greenberg, Paul E., Laura E. Stiglin, Stan N. Finkelstein, et al.. Depression: A Neglected Major Illness, Journal of Clinical Psychiatry, 54(11): 419-424, November 1993.
  • Greenberg, Paul E., Laura E. Stiglin, Stan N. Finkelstein, et al.. The Economic Burden of Depression in 1990 Journal of Clinical Psychiatry, 54(11): 405-418, November 1993.
  • Cockburn, Iain M. and Rebecca M. Henderson. Racing to Invest: The Dynamics of Competition in Ethical Drug Discovery Journal of Economics and Business Strategy. September 1993.
  • Summers, Nevin M. and Charles L. Cooney. Gene Therapy: Biotech's n+1 Technology Biotechnology, 11: February 1993.

Working Papers

Expanded Working Papers List

To request copy of a specific working paper, contact cbi@mit.edu

  • Ellison, Sara F. and Catherine Wolfram. Pharmaceutical Prices and Political Activity National Bureau of Economic Research (NBER) Working Paper No. 8482, August 2001.
  • Ellison, Sara F. and Christopher M. Snyder. Countervailing Power in Wholesale Pharmaceuticals MIT Department of Economics Working Paper 01-27, July 2001.
  • Berndt, Ernst R., Robert S. Pindyck and Pierre Azoulay. Consumption Externalities and Diffusion in Pharmaceutical Markets: Anti-Anti-ulcer Drugs National Bureau of Economic Research (NEBR) Working Paper Series No. 7772, June 2000.
  • Stern, Scott. Do Scientists Pay to be Scientists? National Bureau of Economic Research Papers (NBER) Working Paper No. 7410, October 1999.
  • Cockburn, Iain M., Rebecca Henderson and Scott Stern. The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research National Bureau of Economic Research (NEBR) Working Paper Series No. 7359, September 1999.
  • Berndt, Ernst R., Robert S. Pindyck and Pierre Azoulay. Network Effects and Diffusion in Pharmaceutical Markets:  Antiulcer Drugs National Bureau of Economic Research (NEBR) Working Paper Series No. 7024, March 1999.
  • Cockburn, Iain M., Rebecca Henderson and Scott Stern. Balancing Incentives: The Tension Between Basic and Applied Research National Bureau of Economic Research Papers (NBER) Working Paper No. 6882, January 1999.
  • Ellickson, Paul, Scott Stern and Manuel Trajtenberg. Patient Welfare and Patient Compliance: An Empirical Framework for Measuring the Benefits Of Pharmaceutical Innovation National Bureau of Economic Research Papers (NBER) Working Paper No. 6890, January 1999.
  • Stern, Scott and Manuel Trajtenberg, Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking, National Bureau of Economic Research Papers (NBER) Working Paper No. 6851, December 1998.